Related Experiment Video
Updated: May 10, 2026
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
[Sugammadex use experience in pediatric oncology]
Anesteziologiia I Reanimatologiia
|July 2, 2013
Summary
Sugammadex effectively and rapidly reverses rocuronium-induced neuromuscular blockade in pediatric surgical oncology patients. This study provides crucial data on sugammadex efficacy in this specific young patient population.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Pharmacology
Background:
- Sugammadex is a reversal agent for neuromuscular blockade.
- Limited data exists on sugammadex use in pediatric patients.
- Rocuronium is frequently used for neuromuscular blockade in pediatric surgery.
Purpose of the Study:
- To evaluate the efficacy of sugammadex in reversing rocuronium-induced neuromuscular blockade in pediatric surgical oncology patients.
- To assess the speed and completeness of neuromuscular function recovery.
Main Methods:
- A study involving 42 pediatric patients (ages 2-17) undergoing elective oncology surgeries.
- Neuromuscular blockade was induced using rocuronium.
- Sugammadex was administered for reversal.
- Effectiveness was measured by accelerometer-assessed speed and completeness of myorelaxation reversal.
Main Results:
- Sugammadex demonstrated effectiveness in reversing rocuronium-induced neuromuscular blockade.
- The reversal was rapid and complete, as evidenced by accelerometer measurements.
- The study provides quantitative data on sugammadex performance in pediatric oncology.
Conclusions:
- Sugammadex is an effective agent for the reversal of rocuronium-induced neuromuscular blockade in pediatric surgical oncology patients.
- This study supports the use of sugammadex in this specific pediatric population.
- Further research may explore long-term outcomes and broader pediatric applications.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...